HomeSearch results for “”Page 10

Search.

108 results for ""

Page

Events

 Case Study

Effective Pharmacovigilance & Regulatory EU and Australian Due Diligence, leading to operational and consultative support

 Case Study

Bionical Emas Regulatory Affairs: Mutual Recognition Submission Strategy

 Case Study

Bionical Emas Global Clinical Operations: Rescue Study

 Case Study

Locally sourcing, storing and distributing comparators and ancillaries for a global phase III study

 Case Study

Global EAP for a specialised Biotech company

 Case Study

European EAP with tailored RWD strategy

 Case Study

Global early access program takeover

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.

Contact
COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.